We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current FDMT market cap is 182.96M. The company's latest EPS is USD -3.4726 and P/E is -1.11.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | -19k | 28k | 5k | 3k | 1,000 |
| Operating Income | -36.65M | -38.14M | -42.46M | -51.13M | -56.12M |
| Net Income | -32.28M | -32.4M | -34.95M | -43.84M | -49.67M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 13.61M | 18.04M | 3.13M | 20.72M | 37k |
| Operating Income | -56.66M | -71.33M | -110.03M | -112.87M | -187.84M |
| Net Income | -56.69M | -71.32M | -107.49M | -100.84M | -160.87M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 339.89M | 629.88M | 620.12M | 604.03M | 560.38M |
| Total Liabilities | 32.06M | 29.32M | 31.78M | 51.08M | 49.78M |
| Total Equity | 307.83M | 600.56M | 588.34M | 552.95M | 510.61M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 288.33M | 353.49M | 261.85M | 339.89M | 560.38M |
| Total Liabilities | 31.94M | 34.38M | 30.51M | 32.06M | 49.78M |
| Total Equity | 256.39M | 319.11M | 231.34M | 307.83M | 510.61M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -75.79M | -29.09M | -59.33M | -88.72M | -134.59M |
| Investing | 115.72M | -263.26M | -336.8M | -309.5M | -302.44M |
| Financing | 156.83M | 318.83M | 336.08M | 336.65M | 337.25M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -50.91M | -69.13M | -86.69M | -75.79M | -134.59M |
| Investing | -1M | -172.68M | -17.05M | 115.72M | -302.44M |
| Financing | 278.98M | 118.09M | 3.09M | 156.83M | 337.25M |
| Market Cap | 182.96M |
| Price to Earnings Ratio | -1.11 |
| Price to Sales Ratio | 4.81k |
| Price to Cash Ratio | 1.19 |
| Price to Book Ratio | 0.35 |
| Dividend Yield | - |
| Shares Outstanding | 46.32M |
| Average Volume (1 week) | 530.61k |
| Average Volume (1 Month) | 543.33k |
| 52 Week Change | -84.41% |
| 52 Week High | 28.9269 |
| 52 Week Low | 2.235 |
| Spread (Intraday) | 0.2 (5.06%) |
| Company Name | 4D Molecular Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.4dmoleculartherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
